The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.
The number of anti-vaccine bills filed in Texas has risen, yet many Texans support vaccine policy. Fellow Kirstin R.W. Matthews and nonresident scholar Rekha Lakshmanan examine the stakes of legislative engagement in public health initiatives and provide a call to action for Texans to embrace public health as an act of freedom.
Earlier this year, proposed regulations on video games tanked Chinese gaming stocks. It's a sign that tough governance is ahead — for both digital content industries and governments around the world, writes researcher Brandon Zheng.
For research involving human embryos and other controversial subjects, science journals should require ethics statements from researchers detailing research oversight, what embryos were used, how many and for how long. This will help increase transparency and improve communication with the public, writes Science and Technology Policy Fellow Kirstin R.W. Matthews.
In the fight against Mexican criminal cartels, social network analysis can predict and map out their alliances and subgroups — using algorithms to predict new connections. In this commentary, Nonresident Scholar in Drug Policy and Mexico Studies Nathan P. Jones and his co-authors outline their recent work in the field.
Nathan P. Jones, Oscar Contreras Velasco, John P. Sullivan, Chris Callaghan, Irina Chindea, Daniel Weisz ArgomedoOctober 18, 2023
Federal marijuana legalization is on the horizon — and it’s time for the DEA to get behind the policy changes and move on to fighting more dangerous drugs, writes nonresident fellow Gary Hale.
The latest rivalry between China and Japan is over digital media, specifically over what countries can claim the label of “anime.” But what’s going on is much more complex than the oversimplified “China vs. Japan” narrative, writes research associate Brandon Zheng.
